BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Gujarat Themis Biosyn Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
506879
ISIN Demat
INE942C01045
Book Value (Rs)
26.4090145
NSE Symbol
GUJTHEM
Divident Yield %
0.16
Market Cap
(Rs In Cr.)
4,505
P/E (TTM)
96.6
EPS (TTM)
4.28
Face Value
(Rs)
1
Back
Gujarat Themis Biosyn standalone net profit declines 9.25% in the March 2026 quarter
25-May-26   Hrs IST

Net profit of Gujarat Themis Biosyn declined 9.25% to Rs 10.89 crore in the quarter ended March 2026 as against Rs 12.00 crore during the previous quarter ended March 2025. Sales rose 17.20% to Rs 44.23 crore in the quarter ended March 2026 as against Rs 37.74 crore during the previous quarter ended March 2025.

For the full year,net profit declined 4.29% to Rs 46.68 crore in the year ended March 2026 as against Rs 48.77 crore during the previous year ended March 2025. Sales rose 9.96% to Rs 165.82 crore in the year ended March 2026 as against Rs 150.80 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales44.2337.74 17 165.82150.80 10
OPM %43.7942.50 -45.5545.65 -
PBDT18.3817.32 6 75.0170.91 6
PBT14.3416.09 -11 62.0965.54 -5
NP10.8912.00 -9 46.6848.77 -4

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)